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Abstract: Binding of the competitive inhibitor L-captopril to the dapE-
encoded N-succinyl-L,L-diaminopimelic acid desuccinylase from Neisseria 
meningitidis (NmDapE) was examined by kinetic, spectroscopic, and 
crystallographic methods. L-Captopril, an angiotensin-converting enzyme 
(ACE) inhibitor, was previously shown to be a potent inhibitor of the DapE 
from Haemophilus influenzae (HiDapE) with an IC50 of 3.3 μM and a measured 
Ki of 1.8 μM and displayed a dose-responsive antibiotic activity toward 
Escherichia coli. L-Captopril is also a competitive inhibitor of NmDapE with a 
Ki of 2.8 μM. To examine the nature of the interaction of L-captopril with the 
dinuclear active site of DapE, we have obtained electron paramagnetic 
resonance (EPR) and magnetic circular dichroism (MCD) data for the 
enzymatically hyperactive Co(II)-substituted forms of both HiDapE and 
NmDapE. EPR and MCD data indicate that the two Co(II) ions in DapE are 
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antiferromagnetically coupled, yielding an S = 0 ground state, and suggest a 
thiolate bridge between the two metal ions. Verification of a thiolate-bridged 
dinuclear complex was obtained by determining the three-dimensional X-ray 
crystal structure of NmDapE in complex with L-captopril at 1.8 Å resolution. 
Combination of these data provides new insights into binding of L-captopril to 
the active site of DapE enzymes as well as important inhibitor-active site 
residue interaction’s. Such information is critical for the design of new, potent 
inhibitors of DapE enzymes. 
Graphical abstract 
 
Several pathogenic bacteria, some of which were thought to 
have been eradicated, have made a significant resurgence because of 
bacterial resistance to antibiotics.1,2 According to the Centers for 
Disease Control and Prevention, several bacterial strains currently 
exhibit multidrug resistance, with >60% of hospital-acquired infections 
in the United States caused by the so-called ESKAPE pathogens 
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter 
species).3 To alleviate the problem of antibiotic resistance, it is 
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important that new enzymatic targets be identified and specific 
inhibitors developed.4 The meso-diaminopimelate (mDAP)/lysine bio-
synthetic pathway offers several potential antibacterial enzyme 
targets, such as the dapE-encoded N-succinyl-L,L-diaminopimelic acid 
desuccinylase (DapE).5–7 The products of this pathway, mDAP and 
lysine, are essential components of the peptidoglycan cell wall for 
Gram-negative and most Gram-positive bacteria, providing a link 
between polysaccharide strands.6,8,9 DapE genes have been identified 
in a large number of pathogenic Gram-positive and Gram-negative 
bacteria, including all of the ESKAPE pathogens.10–16 Sequence 
alignment of these DapE genes reveals a minimum of 49% sequence 
identity. Deletion of the gene encoding DapE is lethal to Helicobacter 
pylori and Mycobacterium smegmatis even in the presence of lysine-
supplemented media.10,17 Therefore, DapEs are essential for bacterial 
cell growth and, as there are no similar biosynthetic pathways in 
mammals, are targets for inhibitors that may possess antimicrobial 
activity.5 
DapEs are metalloenzymes that catalyze the hydrolysis of N-
succinyl-L,L-diaminopimelic acid (SDAP), forming L,L-diaminopimelic 
acid and succinate.8 DapEs have been purified from multiple sources, 
but the best characterized example is the DapE from Haemophilus 
influenzae (HiDapE), which is a homodimeric enzyme (subunit Mr = 
41.6 kDa) that requires two Zn(II) ions per mole of polypeptide for full 
enzymatic activity.13 The X-ray crystal structures for both mono- and 
dinuclear Zn(II) forms of HiDapE [Zn_(HiDapE) and ZnZn(HiDapE)] 
have been reported previously.16 In the dinuclear Zn(II) form, each 
Zn(II) ion adopts a distorted tetrahedral geometry coordinated by one 
imidazole (H67 for Zn1 and H349 for Zn2) and one carboxylate group 
(E163 for Zn1 and E135 for Zn2). Both Zn(II) ions are bridged by an 
additional carboxylate group (D100) and a water/hydroxide, forming a 
(μ-aquo)(μ-carboxylato)dizinc(II) core with a 3.3 Å Zn–Zn distance.16 
To date, no X-ray crystallographic data for a DapE–inhibitor complex 
have been reported. 
Thiols are commonly used as inhibitors of Zn(II) metalloproteins 
because Zn(II) is a relatively soft acid and thiols are soft bases.18 
Examination of several thiol-based compounds led to the identification 
of moderately strong inhibitors of HiDapE.14,19 For example, L-
penicillamine exhibits an IC50 value of 13.7 μM toward HiDapE and is a 
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competitive inhibitor with a measured Ki of 4.6 μM. DapE is also 
stereoselective with respect to the recognition of substrate and 
inhibitors, as D-penicillamine provided an IC50 value of 50 μM.14 
Similarly, L-captopril, an angiotensin-converting enzyme (ACE) 
inhibitor, exhibited an IC50 value of 3.3 μM toward HiDapE, while D-
captopril yielded an IC50 value of 42 μM. L-Captopril was shown to be a 
competitive inhibitor of HiDapE with a measured Ki of 1.8 μM and 
displayed a dose-responsive antibiotic activity toward Escherichia 
coli.14 Even though L-captopril is a moderately tight binding inhibitor of 
DapE enzymes and is a promising lead compound for the development 
of a novel class of DapE inhibitors, no information about how L-
captopril binds to DapE, a requirement for the rational design of new, 
more potent DapE inhibitors, has been published. 
A likely important characteristic of a highly specific, tight binding 
inhibitor of DapE enzymes will be the molecule’s ability to bind to the 
metal ions in the active site. Several factors are important for 
interactions of L-captopril with the active site metal ions of DapE, 
some of which are metal coordination geometry, open metal 
coordination sites (i.e., those filled by water molecules), and the 
number of active site metal ions. Therefore, we have analyzed the 
binding of L-captopril to HiDapE and the DapE from Neisseria 
meningitidis (NmDapE) via kinetic and spectroscopic methods. We 
have also determined the X-ray crystal structure of the NmDapE 
enzyme in complex with L-captopril at 1.8 Å resolution. These data 
provide insight into interactions of L-captopril with the active site 
metal ions as well as adjacent active site amino acid residues, 
providing new insight into the rational design of new, more potent 
inhibitors of DapE enzymes. 
Methods 
Materials 
D,L-α,ɛ-Diaminopimelic acid (98%), succinic anhydride, and ion-
exchange resin (Dowex 50WX8-200, H+ form) were purchased from 
Sigma. 2-Naphthalenesulfonic acid 1-hydrate (98%) was purchased 
from TCI, and microcrystalline cellulose was purchased from Merck. All 
other chemicals were purchased from commercial sources and were of 
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the highest quality available. SDAP was synthesized using the 
procedure described by Lin et al.,20 providing an overall yield of 41%. 
Cloning, Expression, and Purification of DapE 
The HiDapE enzyme was expressed and purified as described 
previously.21 The DapE gene from N. meningitidis (NmDapE) was 
cloned into the pMCSG7 vector using the ligation-independent cloning 
method.22 The following primers were used: 5′-TAC TTC CAA TCC AAT 
GCC GCA GCT GCA GCT GCA AAA GAA AAA GTG GTT TCG TTG GCA 
CAA G-3′ and 5′-TTA TCC ACT TCC AAT GTT AGT TAG CTA TCC AAT 
AAA TTC ACT AAC ATT TTG TG-3′. The PCR product was purified using 
the QIAquick PCR Purification Kit (Qiagen) to remove the primers and 
dNTPs from the PCR mixture. T4 polymerase was employed to create 
overhangs on the PCR fragments. The resulting plasmid was 
transformed into BL21(DE3)/magic E. coli competent cells and grown 
in Luria-Bertani broth containing ampicillin (150 μg mL−1) and 
kanamycin (25 μg mL−1) at 37 °C to an A600 of 1.0 while being shaken. 
IPTG was added (0.4 mM), and culture growth was continued for 16 h 
at 18 °C. Cells were recovered by centrifugation (12000g) for 15 min 
at 4 °C using a Beckman Coulter Avanti J-E Centrifuge. NmDapE was 
purified according to the standard protocol for Ni-NTA affinity 
chromatography, and all steps were performed at 4 °C.23 The His6 tag 
was removed by treating each enzyme with His6-tagged TEV protease 
for 16 h at 4 °C in 50 mM HEPES (pH 8.0). Cleaved protein was 
separated from His6-tagged TEV using Ni-NTA affinity chromatography. 
Enzymatic Assay 
The specific activity of HiDapE and NmDapE was determined 
using a 50/50 mixture of D,D- and L,L-SDAP as the substrate in 50 
mM phosphate buffer (PPi) (pH 7.5) as previously described.24 The 
kinetic parameters Vmax and Km were determined by quantifying amide 
bond cleavage (decrease in absorbance) of L,L-SDAP at 225 nm (ɛ = 
698 M−1 cm−1) in triplicate using a Shimadzu UV-2450 
spectrophotometer equipped with a temperature controller (25 °C). 
Enzyme activities are expressed as units per milligram, where 1 unit is 
defined as the amount of enzyme that releases 1 μmol of L,L-SDAP at 
30 °C in 1 min. Catalytic activities were determined with an error of 
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±10%. Initial rates were fit directly to the Michaelis–Menten equation 
to obtain the catalytic constants Km and kcat using Origin software. 
Inhibition of NmDapE by L-Captopril 
The kinetic parameters v (velocity), kcat (Vmax/[E]0), Km 
(Michaelis constant), and Ki (inhibition constant) were determined in 
50 mM phosphate buffer (pH 7.5) spectrophotometrically by recording 
the initial velocity of the hydrolysis of L,L-SDAP at 25 °C in triplicate.14 
L-Captopril concentrations ranged from 0 to 0.1 mM. The linearity of 
the progress curves for product formation in the absence and presence 
of an inhibitor indicated that L-captopril is in rapid equilibrium with 
NmDapE. The initial rates were plotted against substrate 
concentration, and the kinetic constants were calculated using Origin 
software.20,24,25 
Co(II)-Substituted DapE Samples 
Apo-DapE was prepared by extensive dialysis for 72 h at 4 °C 
against 10 mM EDTA in 50 mM HEPES buffer (pH 7.5). DapE was then 
exhaustively dialyzed against metal-free (Chelex-100 treated) 50 mM 
HEPES buffer (pH 7.5). Any remaining metal ions were estimated by 
comparing the activity of the apoenzyme with that of a sample that 
had been reconstituted with Zn(II). DapE incubated with EDTA 
typically had <5% residual activity after dialysis. The mono- and 
dicobalt(II) forms of HiDapE and NmDapE were prepared using apo-
DapE samples that were incubated with CoCl2 (99.999%; Strem 
Chemicals, New-buryport, MA) for 30 min at 25 °C prior to exhaustive 
dialysis into Chelex-100-treated buffer as previously reported.26 
Electron Paramagnetic Resonance Spectroscopy 
Electron paramagnetic resonance (EPR) spectra were recorded 
at 4.5–35 K and 9.63 GHz (ER4116DM resonator with B0⊥B1), 9.37 
GHz (ER4116DM resonator with B0‖B1), or 9.39 GHz (SHQ resonator) 
using 1.2 mT (12 G) magnetic-field modulation at 100 kHz with phase-
sensitive detection on a Bruker EleXsys E600 spectrometer equipped 
with an Oxford Instruments ESR900 helium flow cryostat and ITC503 
temperature controller. The SHQ resonator has a B1 for a given 
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microwave power significantly higher than that of the ER4116DM 
resonator (we estimate by a factor of ~5). Background signals were 
collected on samples of frozen buffer and subtracted. 
Magnetic Circular Dichroism Studies 
The magnetic circular dichroism (MCD) instrument consists of a 
JASCO J815 spectropolarimeter and an Oxford Instruments SM4000 
cryostat/magnet. Variable-temperature variable-field (VTVH) MCD data 
were collected in increments of 0.5 T (T) from 0 to 7.0 T and at 
temperatures (nominally) of 1.5, 3.0, 6.0, 12, 24, and 48 K. Spectra 
were collected at a 1.0 nm bandwidth and scanned at 50 nm/min using 
a time constant of 1 s. The sample cell has a 0.62 cm path length. 
Each spectrum was corrected for any natural CD by subtracting the 
zero-field spectrum of the sample. Even when there is no sample 
present, the instrument baseline exhibits a small deviation from zero 
that is both field- and wavelength-dependent. Therefore, each 
spectrum was also corrected by subtraction of a spectrum recorded at 
the same magnetic field but with no sample present. The MCD spectra 
were fit to the minimal number of Gaussian peaks using Grams AI 9.1 
after converting the spectra to wavenumber units. In the fitting 
process, a minimal number of Gaussians were fit to achieve a 
satisfactory composite spectrum. Fitting of the VTVH MCD data was 
achieved using a Fortran program, VTVH 2.1.1, written by M. Riley.27 
The spin Hamiltonian and additional details of the fitting program have 
been described previously.28 The fits were tested for robustness once a 
complete set of parameters had been obtained. To do this, the initial 
parameters were set to the best-fit parameters and then all allowed to 
float. Subsequently, one key parameter such as J, D, Mxy, Mxz, or Myz 
was chosen, and its initial value was set differently, after which the fit 
process was repeated. Percent polarization for a given fit was 
calculated from Mxy, Myz, and Mxz using %Mx = (Mxy × Myz)2/[(Mxy × 
Mxz) + (Mxy × Myz)2 + (Mxz × Myz)2]. My and Mz were calculated 
correspondingly.29 Finally, the VTVH MCD data fitting program used a 
spin Hamiltonian that included the term H = −2JS1S2. 
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Protein Crystallization 
Prior to crystallization, a 25 mg/mL NmDapE protein sample was 
incubated with 3 equiv of Zn(II) ions and left on ice for 20 min to 
equilibrate. Zinc(II)-loaded NmDapE was screened against 300 
commercially available conditions (Index HT and PEG/Ion HT from 
Hampton Research and Wizard TM from Emerald Biosystems) using a 
Mosquito liquid handling robot with 96 plates.30 Several crystallization 
conditions were characterized yielding diffraction quality crystals. All 
crystals were screened, and data were collected on the best-diffracting 
crystals, which were grown by the sitting-drop vapor-diffusion method 
at 16 °C using 400 nL of a precipitant solution [20% (w/v) PEG 3350 
and 100 mM HEPES (pH 7.5)] and 400 nL of [ZnZn(NmDapE)]. X-ray 
quality crystals appeared within 2 weeks. Crystals of [Zn_NmDapE] 
were also crystallized by the sitting-drop vapor-diffusion method at 
16 °C but with a 400 nL precipitant solution [15% (w/v) PEG 3350 and 
100 mM succinic acid (pH 7.0)] and 400 nL of a protein, providing 
crystals within 2 weeks. Crystals of [ZnZn(NmDapE)] in complex with 
L-captopril were obtained by mixing 400 nL of a precipitant solution 
[0.2 M ammonium acetate, 0.1 M TRIS (pH 8.5), and 25% (w/v) 
polyethylene glycol 3350] in a 1:1 ratio with a solution of 
[ZnZn(NmDapE)] incubated with a 30 mM solution of L-captopril [50 
mM HEPES (pH 7.5) and 150 mM NaCl] with crystals appearing within 
3 weeks. 
Structure Solutions and Refinement 
The X-ray data were collected at beamline 19-ID of the 
Structural Biology Center at the Advanced Photon Source.31 All data 
were processed and scaled using HKL3000.32 Molecular replacement 
searches were completed with MOLREP within the CCP4 suite using the 
structure of apo-NmDapE as a template [Protein Data Bank (PDB) 
entry 1VGY].16 The asymmetric unit of [Zn_(NmDapE)] (space group 
P212121) contains a dimer, while crystals of [ZnZn(NmDapE)] and 
[ZnZn(NmDapE)] in complex with L-captopril both crystallized in the 
C2221 space group and contained only one subunit of the dimer in the 
asymmetric unit. Several rounds of rebuilding and readjusting using 
COOT33 and refinement using REFMAC34 and PHENIX35 improved the 
initial models. The final models were refined against 95% of the 
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reflections within the resolution ranges. The remaining 5% of the 
reflections, which were randomly selected, were used to monitor Rfree. 
The final refinement statistics are listed in Table 1. Analysis and 
validation of all structures were performed with the aid of PROCHECK36 
and MOLPROBITY.37 The refinement restraints for the L-captopril 
structure were created with the assistance of COOT and were 
generated from SMILE string.38 
Table 1. Data and Refinement Statistics 
 
[Zn_NmDapE] [ZnZn_NmDapE] [ZnZn_NmDapE]-L-
captopril 
Data Collection 
space group unit cell (Å) P212121 C2221 C2221 
a = 55.3 a = 117 a = 116.9 
b = 111.4 b = 151.6 b = 151.5 
c = 132.5 c = 55.5 c = 55.1 
resolution (Å) 39.2–2.09 29.4–2.0 27.5–1.78 
wavelength (Å) 0.98 0.98 0.98 
no. of observed 
reflections 
204709 202836 178375 
no. of unique reflections 48738 33502 46112 
redundancyb 4.2 (4.0) 6.1 (5.8) 3.9 (3.8) 
Rmergea,b (%) 7.4 (82.1) 8.5 (89.9) 6.5 (75.2) 
Rpima,b (%) 4.0 (45.7) 4.3 (59.4) 3.3 (44.2) 
completenessb (%) 99.1 (96.7) 100 (100) 97.7 (99.5) 
I/σ 17.9 (1.5) 22.8 (1.9) 17.7 (1.7) 
phasing 
   
 phasing method MR MR MR 
Refinement 
Rcryst (%) 21.3 17.5 16.4 
Rfree (%) 24.1 20.8 19.6 
no. of protein residues 746 374 374 
no. of 
zinc/phosphate/sulfate 
ions 
3/–/4 2/1/– 2/–/1 
no. of solvent molecules 380 237 284 
rmsd from target values 
   
 bond lengths (Å) 0.003 0.020 0.021 
 bond angles (deg) 0.71 1.69 1.90 
average B factor (Å2) 
   
 protein 43.8 32.2 24.8 
 Zn 32.0 23.2 17.9 
 H2O 37.8 24.19 34.6 
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[Zn_NmDapE] [ZnZn_NmDapE] [ZnZn_NmDapE]-L-
captopril 
PDB entry 4O23 4PPZ 4PQA 
Ramachandran (%)c 
MF/AA 
97.4/2.6 97.6/2/4 97.9/2.1 
aRmerge = ΣhklΣi|Ii(hkl) − ⟨Ihkl⟩|/ΣhklΣiIi(hkl), where Ii(hkl) is the ith observation of reflection 
hkl and ⟨Ihkl⟩ is the weighted average intensity for all observations i of reflection hkl. 
Rpim=∑hkl[1/(N−1)1/2]∑i∣∣Ii(hkl)−¯I¯hkl∣∣/∑hkl∑iIi(hkl). 
bNumbers in parentheses are values for the highest-resolution bin. 
cAs defined by MOLPROBITY (MF, most favored, AA, additionally allowed). 
PDB Coordinates 
The atomic coordinates for [Zn_(NmDapE)], [ZnZn(NmDapE)], 
and [ZnZn(NmDapE)] bound by L-captopril were deposited in the PDB 
as entries 4O23, 4PPZ, and 4PQA, respectively. 
Results 
Kinetic Studies of [Zn_(NmDapE)] and [ZnZn-
(NmDapE)] 
Steady-state kinetic parameters for the hydrolysis of L,L-SDAP 
by [Zn_(NmDapE)] and [ZnZn(NmDapE)] and [Zn_(HiDapE)] and 
[ZnZn(HiDapE)] are listed in Table 2. The kinetic parameters obtained 
for Zn(II)-loaded NmDapE are very similar to those previously 
reported for Zn(II)-loaded HiDapE.14 Of note is the lack of dependence 
of Km on the zinc content, while the dizinc forms exhibit almost twice 
the catalytic efficiency of the monozinc forms. L-Captopril was found to 
be a competitive inhibitor of [ZnZn(NmDapE)] with a Ki of 2.8 μM, a 
value similar to that observed for [ZnZn(HiDapE)] (Ki of 1.8 μM). 
Table 2. Kinetic Constants for [Zn_(DapE)] and [ZnZn(DapE)] from N. 
meningitidis and H. influenza  
NmDapE  
 
HiDapE  
 
Zn ZnZn Zn ZnZn 
Km (μM) 795 ± 20 610 ± 11 730 ± 15 730 ± 15 
kcat (s−1) 76 ± 10 120 ± 10 80 ± 5 140 ± 10 
kcat/Km (mM−1 min−1) 5700 ± 200 11800 ± 200 6600 ± 200 11400 ± 200 
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EPR Spectra of L-Captopril Bound to [Co_(NmDapE)], 
[CoCo(NmDapE)], [Co_(HiDapE)], and [CoCo(HiDapE)] 
EPR spectra of the resting forms of Co(II)-substituted NmDapE 
(Figure 1A) and HiDapE (Figure 1B) reveal clear similarities. At 13 K 
and a nonsaturating microwave power, the [Co_(DapE)] spectra 
(traces A in panels A and B of Figure 1) are complex and appear to be 
due to a moderately rhombic (E/D ≤ 0.15) MS = ±½ signal with 
resonances at g′ = 5.35 (1250 G), 4.05 (1660 G), and 2.25 (3015 G), 
superimposed on an MS = ±3/2 signal with a sharp resonance at g′ = 
6.5 (1030 G) and a broad derivative feature with an estimated turning 
point at g′ ≈ 1.15. At 4.5 K and a high microwave power (traces B in 
panels A and B of Figure 1), the MS = ±½ signals are almost 
completely extinguished. This latter behavior indicates that the MS = 
±½ signals are due to thermal population of the MS = ±½ Kramers’ 
doublet at a higher temperature associated with an excited state with 
a zero-field splitting, Δ, on the order of 10 cm−1 for [Co_(NmDapE)], 
and less for [Co_(HiDapE)], where some MS = ±½ contribution is still 
evident at 4.5 K (1 cm−1 corresponds to 1.44 K). If the MS = ±½ 
signals were ground-state signals due to a distinct chemical species, 
rapid-passage signals would be expected rather than disappearance or 
diminution of the signals.39 These data indicate a preferred binding site 
with an MS = ±3/2 ground state, suggesting a distorted tetrahedral 
coordination environment.39 
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Figure 1. (A) EPR spectra at 9.39 GHz (SHQ resonator) of [Co_(NmDapE)] (A and B) 
and [CoCo(NmDapE)] (C and D), recorded at 13 K and 0.5 mW (A and C) and 4.5 K 
and 100 mW (B and D). Spectral amplitudes are shown normalized for 1/T, 
(Pmicrowave)1/2, and the number of equivalents of Co(II) added. (B) EPR spectra at 9.39 
GHz (SHQ resonator) of [Co_(HiDapE)] (A and B) and [CoCo(HiDapE)] (C and D), 
recorded at 13 K and 1.0 mW (A and C) and 4.5 K and 200 mW (B and D). Spectral 
amplitudes are shown normalized for 1/T, (Pmicrowave)1/2, and the number of equivalents 
of Co(II) added. 
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Upon addition of a second equivalent of Co(II), a poorly 
resolved and apparent MS = ±½ signal was observed at 13 K (traces C 
in panels A and B of Figure 1). In addition, a very weak but clearly 
identifiable 59Co hyperfine pattern with Az = 90 G was observed on the 
low-field edge of the MS = ±½ signal, centered at g′ = 7.9 (850 G; 
see, e.g., Figure 1A, trace C), but is not clearly visible at the scale 
used in panels A and B of Figure 1. This hyperfine signal could be due 
to a small amount of an additional MS = ±3/2 signal with greal(z) ~ 2.6 
or else a very rhombic (E/D ~ 1/3) MS = ±½ signal with greal(y) ~2.9; 
the origin of the hyperfine split signal is unclear, but it was completely 
insensitive to L-captopril and was not considered further. 
In contrast to the case for [Co_(NmDapE)] and [Co_(HiDapE)], 
when EPR spectra of [CoCo(NmDapE)] and [CoCo(HiDapE)] were 
recorded at 4.5 K, the predominant MS = ±½ signal was clearly still 
observable as a rapid-passage signal that appeared as an inverted 
absorption-shaped feature, superimposed on the sharp MS = ±3/2 
signal at g′ = 6.5 (traces D in panels A and B of Figure 1). The 
appearance of a slowly relaxing ground-state MS = ±½ signal is 
consistent with the second added equivalent of Co(II) occupying a 
five- or six-coordinate site. There is a slight difference between the 
signals from [CoCo(NmDapE)] and [CoCo(HiDapE)]. The signal from 
[CoCo(NmDapE)] appears to account for the entire complement of 
Co(II), whereas that from [CoCo(HiDapE)] indicates that some EPR 
silent Co(II) is present. Further, the MS = ±3/2 signal in 
[CoCo(HiDapE)] is significantly smaller than in [Co_(HiDapE)] (traces 
D and B, respectively, in Figure 1B), whereas this is not the case in 
[CoCo(NmDapE)] (traces D and B, respectively, in Figure 1A; note that 
in both panels A and B of Figure 1, traces D have been multiplied by 
0.5 relative to traces B to account for 2 vs 1 equiv of Co2+). These data 
suggest a weak antiferromagnetic interaction between the Co(II) ions 
in [CoCo(HiDapE)], such that |J| > hν for some, but not all, of the 
population of dinuclear centers in the sample, i.e., that there is a 
distribution of J that includes 0.3 cm−1. No parallel mode (B0‖B1) EPR 
signals were observed. 
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Addition of L-captopril induced differential effects in 
[CoCo(NmDapE)] and [CoCo(HiDapE)] 
Addition of L-captopril to [CoCo(NmDapE)] resulted in the sharp 
MS =±3/2 signal at g′ = 6.5 being essentially extinguished, but no 
overall signal intensity was lost (Figure 2, traces A and B). This is 
consistent with additional coordination to the hitherto four-coordinate 
Co(II) ion but no mediation of significant (≥0.3 cm−1) exchange 
coupling between the two Co(II) ions. In contrast, the addition of L-
captopril to [CoCo(HiDapE)] leads to a wholesale loss of ~30% of the 
EPR intensity, with no detectable change in line shape (Figure 2, traces 
C and D), signifying an increase, albeit modest, in the level of 
exchange coupling between the two Co(II) ions. 
 
Figure 2. EPR spectra at 9.63 GHz (ER4116DM resonator) of [CoCo(NmDapE)] before 
(A) and after (B) the addition of L-captopril and [CoCo(HiDapE)] before (C) and after 
(D) the addition of L-captopril. Spectra were recorded at 4.5 K and 100 mW. Spectral 
amplitudes are shown normalized for 1/T, (Pmicrowave)1/2, and the number of equivalents 
of Co(II) added. 
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MCD Spectra of L-Captopril Bound to [Co_(NmDapE)], 
[CoCo(NmDapE)], [Co_(HiDapE)], and [CoCo(HiDapE)] 
MCD spectra of [CoCo(NmDapE)] and [CoCo(HiDapE)] are 
nearly identical in shape, band energy, and intensity (Figure 3). It 
should be noted that the MCD spectra obtained at ambient 
temperature in the absence of a glycerol glassing agent have the same 
bands as the low-temperature spectra; however, they are much less 
intense and broader. All of the bands display temperature-dependent 
C-terms arising from the paramagnetic high-spin Co(II) ground states. 
The intense negative band at 576 nm is asymmetric because of a small 
component at 559 nm in [CoCo(HiDapE)] and at 558 nm in 
[CoCo(NmDapE)]. This intense negative band along with an intense 
positive band at 532 nm is characteristic of high-spin Co(II) in a 
distorted tetrahedral ligand field.40–42 These bands arise from the 4A2 → 
4T1(P) d−d transition in Td that has been split into three components by 
the lowe-symmetry environment in the active site. The negative band 
at 503 nm along with a very weak positive band at shorter 
wavelengths is characteristic of high-spin Co(II) in a distorted 
octahedral ligand field.40,41,43,44 The band at 503 nm arises from the 
4T1g → 4T1g(P) d–d transition in Oh that can broaden or split at lower 
symmetries. The 503 nm band does not split in [CoCo(NmDapE)] or 
[CoCo-(HiDapE)] but is noticeably broader in [CoCo(HiDapE)] than in 
[CoCo(NmDapE)]. The very weak positive bands at 463 and 475 nm in 
[CoCo(HiDapE)] and [CoCo(NmDapE)], respectively, are doublet 
transitions, which gain intensity through spin–orbit coupling to the 
nearby spin-allowed 503 nm band.43 Despite the similarity in the MCD 
spectra of [CoCo(HiDapE)] and [CoCo(NmDapE)], there is a difference 
in the relative metal binding affinities between the two enzymes. When 
1 equiv of Co(II) is added to apo-NmDapE, both the six-coordinate and 
four-coordinate sites are partially occupied (Figure SI-1 of the 
Supporting Information). Addition of a second equivalent of Co(II) 
saturates both binding sites. On the other hand, addition of 1 equiv of 
Co(II) to apo-HiDapE saturates the four-coordinate site, leaving the 
six-coordinate site virtually empty (Figure SI-2 of the Supporting 
Information). 
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Figure 3. MCD spectra of (A) [CoCo(HiDapE)] (top) and [CoCo(NmDapE)] (bottom) 
and (B) [CoCo(HiDapE)] with 5 equiv of L-captopril (top) and [CoCo(NmDapE)] with 5 
equiv of L-captopril (bottom). All spectra were recorded at 1.3 K and 7.0 T in a 0.62 
cm path length cell. The enzymes were in a 60/40 (v/v) glycerol/buffer solution. 
[CoCo(HiDapE)] at 32 mg/mL [0.77 mM enzyme, 1.6 mM in active sites, 3.1 mM in 
Co(II)]. [CoCo(NmDapE)] at 29 mg/mL [0.70 mM enzyme, 1.4 mM in active sites, 2.8 
mM in Co(II)]. The units of Δɛ/H are M−1 cm−1 T−1, where the concentration of active 
sites was used. In both panels, the blue trace is the experimental spectrum and the 
red traces are the Gaussians used to fit the spectra. 
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VTVH MCD data were collected at 503, 532, and 576 nm on 
both [CoCo(NmDapE)] and [CoCo(HiDapE)]. These data were used to 
construct magnetization plots; typical examples are shown in Figures 
SI-3–SI-8 of the Supporting Information. The VTVH MCD data were fit 
as previously described,27 which yielded the electronic ground-state 
parameters for magnetic exchange coupling (J) and axial (D) and 
rhombic (E) zero-field splitting (ZFS). Typical fits are also shown in 
Figures SI-3–SI-8 of the Supporting Information. Multiple experiments 
were run, and average values of these parameters along with the 
standard deviations are given in Table 3. Magnetic exchange coupling, 
if it occurs, will be strongest through monatomic bridges (e.g., μ-1,1 
as opposed to μ-1,3). In none of the fittings of the VTVH data from 
[CoCo(NmDapE)] or [CoCo(HiDapE)] was the quality of the fit 
improved (lower value of χ2) by having a nonzero J (positive or 
negative). This strongly suggests that the bridging oxygen atom is in 
the form of a μ-aqua as opposed to a μ-hydroxo. Many dicobalt(II) 
complexes with either a μ-aqua or μ-hydroxo have been studied.8,44–46 
Aqua-bridged complexes consistently exhibit a small antiferromagnetic 
coupling (negative J) or no coupling at all, whereas hydroxo-bridged 
complexes consistently have a small ferromagnetic (positive J) 
coupling. In addition to the previously reported dicobalt(II) complexes, 
three new model complexes that are consistent with this trend are 
shown in Figures SI-13 and SI-14 of the Supporting Information. The 
ZFS parameters that were determined in the fitting of the VTVH data 
from [CoCo-(NmDapE)] and [CoCo(HiDapE)] were also consistent with 
assignment of the 503 nm band to a six-coordinate Co(II), and the 
532 and 576 nm bands to a distorted four-coordinate Co(II). 
Generally, the axial ZFS parameter, D, is >50 cm−1 for six-coordinate 
high-spin Co(II) and <10 cm−1 for four-coordinate high-spin Co(II).8,42 
Table 3. VTVH MCD Fitting Parameters 
parameter [CoCo(NmDapE)]a [CoCo(NmDapE)] 
and captoprilb 
[CoCo(HiDapE)]c [CoCo(HiDapE)] 
and captoprild 
J (cm−1) 0 −0.1 0 −0.05 ± 0.04 
D (cm−1), 
4C 
3.7 ± 0.6 0.05 3.7 ± 1.0 4.1 ± 1.5 
E/D, 4C ~0 0.002 ~0 0.25 ± 0.14 
D (cm−1), 
6C 
>100 >50 >100 28 ± 5 
E/D, 6C 0.18 ± 0.04 ~0 0.27 ± 0.04 0.08 ± 0.03 
polarization 503 nm x-pol. 505 nm na 503 nm x-pol. 505 nm z-pol. 
 
532 nm xy-pol. 530 nm na 532 nm xy-pol. 530 nm z-pol. 
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parameter [CoCo(NmDapE)]a [CoCo(NmDapE)] 
and captoprilb 
[CoCo(HiDapE)]c [CoCo(HiDapE)] 
and captoprild 
 
576 nm xy-pol. 604 nm z-pol. 576 nm xy-pol. 604 nm z-pol. 
aBased on three independent experiments; ±one standard deviation. 
bBased on a single experiment. 
cBased on eight independent experiments. 
dBased on four independent experiments. 
The addition of 1 equiv (based on the concentration of active 
sites) of L-captopril to either [CoCo(HiDapE)] or [CoCo-(NmDapE)] has 
no apparent effect on the MCD spectra. However, addition of 5 equiv 
of L-captopril causes the green resting enzyme solutions to turn blue 
(Figure 3B). The four-coordinate Co(II) bands shift from 532, 559, and 
576 nm in [CoCo(HiDapE)] to 530, 565, and 604 nm, respectively, in 
the [CoCo(HiDapE)]–L-captopril complex, while the bands for the same 
species shift from 532, 558, and 576 nm in [CoCo(NmDapE)] to 530, 
565, and 604 nm, respectively, in the [CoCoNmDapE]–L-captopril 
complex. The six-coordinate band at 503 nm splits into two bands at 
488 and 505 nm for the [CoCo(HiDapE)]–L-captopril and 
[CoCo(NmDapE)]–L-cap-topril complexes. There is a small peak at 576 
nm in both spectra, which is due to uncomplexed enzyme. In addition 
to these band shifts, there is a roughly 3-fold decrease in MCD 
intensity, which is not due to loss of Co(II) from the enzyme caused by 
L-captopril. Finally, the quality of the optical glasses formed in the 
presence of L-captopril is not as high as for the resting enzyme alone. 
The resulting MCD spectra had signal-to-noise ratios considerably 
lower than those of the MCD spectra obtained for the resting enzymes. 
VTVH MCD data were also collected on the 505, 530, and 604 
nm bands in the [CoCo(HiDapE)]–L-captopril complex and only for the 
604 nm band in the [CoCo(NmDapE)]–L-captopril complex. Example 
magnetization plots and fits are shown in Figures SI-9–SI-12 of the 
Supporting Information. The χ2 values for fits of the 505 and 530 nm 
data are quite high as is the χ2 value for the 604 nm data for the 
[CoCo-(NmDapE)]–L-captopril complex. The best fits were obtained 
with a small negative value for J. In addition, the ZFS parameters for 
both the six- and four-coordinate sites changed but were still in the 
ranges expected for the corresponding Co(II) species (Table 3). 
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Crystal Structures of [Zn_(NmDapE)], [ZnZn-
(NmDapE)], and the L-Captopril-Bound 
[ZnZn(NmDapE)] Complex 
The X-ray crystal structures of [Zn_(NmDapE)] (2.1 Å), 
[ZnZn(NmDapE)] (2.0 Å), and the [ZnZn-(NmDapE)]–L-captopril 
complex (1.8 Å) were determined. These three structures along with 
that of apo-NmDapE, which was previously determined (PDB entry 
1VGY),47 reveal the typical two-domain homodimer structure (either 
present in the asymmetric unit or generated by the crystallographic 2-
fold axis) observed for all DapE enzymes. Comparison of all four 
structures of NmDapE shows that the overall fold is well-preserved and 
the structures of the apo, monozinc, dizinc, and L-captopril-bound 
forms are nearly identical. Each of these structures overlays with an 
rmsd for Cα atoms of 0.59 Å {apo-NmDapE over [Zn_(NmDapE)]} and 
0.73 Å {apo-NmDapE over [ZnZn(NmDapE)] and L-captopril-bound 
[ZnZn-(NmDapE)]}. Close analysis of the [ZnZn(NmDapE)] and 
[ZnZn(NmDapE)]–L-captopril structures [both were determined from 
isomorphous crystals grown under similar conditions (Table 1)] reveals 
that inhibitor binding does not introduce any significant changes into 
the structure as evidenced by a very low rmsd of 0.2 Å. Furthermore, 
examination of the active site regions of the [ZnZn(NmDapE)] 
structure indicates that the metal ions and ligands are in nearly 
identical positions. The dinuclear Zn(II) active sites in both 
[ZnZn(NmDapE)] and the [ZnZn(NmDapE)]–L-captopril complex adopt 
coordination geometries identical to that reported for HiDapE.16 
For [ZnZn(NmDapE)], the first metal binding site, Zn1, resides 
in a distorted tetrahedral geometry and is bound by the carboxylate 
OD1 atom of D101 and OE1 atom of E164 as well as the NE1 atom of 
H68. The Zn2 metal ion resides in a distorted trigonal bipyramidal 
geometry and is bound by the NE2 atom of H350, two oxygen atoms, 
OD2 from D101 and OE2 from E136, and the O1 atom of ethylene 
glycol. Interestingly, for [Zn_(NmDapE)] a full dimer resides in the 
asymmetric unit, and Zn(II) binding is different between the two 
active sites. In one of the active sites, a single Zn(II) ion is bound in 
the first metal binding site, while in the second active site, two Zn(II) 
ions are present but with occupancies modeled at 60% for Zn1 and 
18% for Zn2. These data suggest that metal binding is not strictly 
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sequential for NmDapE, which is different from that observed for 
HiDapE. 
The 1.8 Å structure of the [ZnZn(NmDapE)]–L-captopril complex 
reveals clear electron density corresponding to L-captopril inside the 
positively charged groove, formed between the catalytic and 
dimerization domains (Figure 4). The sulfhydryl group of L-captopril 
bridges the two active site Zn(II) ions with Zn–S distances of 2.3 Å, 
displacing the bridging water molecule. The carboxylate of the proline 
moiety of L-captopril forms a hydrogen bond with N346 (ND2–O3, 3.0 
Å) and the amide of G325 (N–O2, 2.9 Å). It also makes a strong 
hydrogen bond with the hydroxyl of Y198 (OH–O3, 2.5 Å), which 
reaches over from the second subunit of the dimer. The O1 peptide 
carbonyl oxygen of L-captopril forms a hydrogen bond with a well-
ordered water molecule (2.8 Å) that is stabilized by its interaction with 
R179 (NH2–O, 3.1 Å) and P165 (2.6 Å). 
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Figure 4. Structure of the [ZnZn(NmDapE)]–L-captopril complex. (A) Ribbon diagram 
of the homodimer of [ZnZn(NmDapE)] (subunit A colored orange and subunit B blue). 
The Zn(II) ions in the dinuclear active site are shown as black spheres, while 
molecules of L-captopril are shown as green sticks. (B) Close-up of the active site 
region showing the hydrogen bonding interactions of L-captopril (green) with 
surrounding protein residues and solvent molecule (red sphere). The active site 
residues are color-coded (orange and blue sticks) according to the subunit coloring, 
while the conserved residues binding to the Zn(II) ions are colored gray. (C) 
Schematic drawing of the dinuclear Zn(II) active site bound by L-captopril (distances 
in angstroms).  
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Discussion 
EPR spectra of [Co_(NmDapE)] and [Co_(HiDapE)] suggest the 
first Co(II) ion to bind resides in a distorted tetrahedral coordination 
geometry at low temperatures, and this assignment is consistent with 
the crystallographic and MCD data. EPR spectra of [CoCo(NmDapE)] 
and [CoCo(HiDapE)] suggest a five- or six-coordinate Co(II) ion in the 
second metal binding site. The EPR data also indicate an 
antiferromagnetic interaction due to the formation of a spin-coupled 
species with | J| > 0.3 cm−1 between the Co(II) ions in 
[CoCo(HiDapE)] but no interaction was detected in 
[CoCo(NmDapE)];24 some 30% of the Co(II) in [CoCo(HiDapE)] is EPR 
silent. EPR of the L-captopril complexes of both [CoCo(NmDapE)] and 
[CoCo(HiDapE)] indicated that the hitherto tetrahedral Co(II) ion 
acquired an additional ligand(s) and modulated the spin coupling in the 
latter (Figure 2), consistent with the captopril-derived thiolate bridge 
observed in the crystal structure (Figure 4). For both [CoCo(NmDapE)] 
and [CoCo(HiDapE)], characteristic MCD bands for high-spin Co(II) in 
a distorted tetrahedral and distorted octahedral ligand field are 
observed (Figure 3), consistent with EPR data. An interesting finding is 
that despite the similarity in the MCD spectra between 
[CoCo(NmDapE)] and [CoCo(HiDapE)], the spectra obtained for 
[CoCo(NmDapE)] reveal that both the four- and six-coordinate sites 
are occupied upon the addition of only 1 equiv of Co(II), suggesting a 
less than strictly sequential binding model for NmDapE that is not 
observed for HiDapE. This finding is consistent with EPR data as well 
as the X-ray crystal structure of [Zn_(NmDapE)]. 
Correlation of the ZFS observed by MCD with coordination 
number was used as a coordination number indicator (termed the 
CN/ZFS correlation). In the CN/ZFS correlation, four- coordinate Co(II) 
exhibits ZFS < 13 cm−1, also observed directly here by EPR; five-
coordinate between 20 and 50 cm−1; and six-coordinate above 50 
cm−1.48 The ZFS parameters determined from fits of VTVH data for 
[CoCoNmDapE] and [CoCoHiDapE] are consistent with four-coordinate 
and six-coordinate Co(II) centers in the active site. On the basis of 
previously published magnetic properties of several μ-aqua μ-hydroxo 
dicobalt(II) model complexes, weak to moderately strong 
antiferromagnetic coupling would be expected from a single oxygen 
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atom bridge.49,50 Fitting of the VTVH data from [CoCoNmDapE] and 
[CoCoHiDapE] strongly suggests that the bridging oxygen atom, in the 
resting enzyme, is due to μ-aqua as opposed to μ-hydroxo moieties. 
MCD data of the L-captopril complexes are consistent with the thiol of 
L-captopril bridging the two active site Co(II) ions, producing an 
antiferromagnetically coupled dicobalt(II) center with an S = 0 ground 
state. The overall changes strongly suggest that L-captopril displaces 
the bridging water molecule and binds to both metal ions through a 
monatomic bridge whose ligand-field strength is less than that of 
water. These findings are consistent with EPR data for [CoCoHiDapE] 
bound by L-captopril. Taken together, the optical, magneto-optical, 
and EPR results are in strong agreement and indicate that L-captopril 
interacts directly with both metal ions. 
Additional structural information was obtained from X-ray 
crystallography, including the finding that no active site ligands are 
displaced upon L-captopril binding except for replacement of the water 
molecule that bridges the two Zn(II) ions in the wild-type enzyme by 
the L-captopril-derived thiolate sulfur atom. The remainder of the 
molecular structure of DapE is barely perturbed, but some significant 
hydrogen bonds to L-captopril that likely identify residues important 
for substrate and inhibitor recognition and/or binding are formed. The 
binding of L-captopril to the dinuclear active site of [ZnZn-(NmDapE)] 
provides the first structural data for an inhibited form of any DapE 
enzyme, providing a model for inhibitor design as well as enzyme–
substrate interactions. 
Inspection of the X-ray crystal structures of [Zn_(NmDapE)] and 
[ZnZn(NmDapE)], combined with surface analysis, reveals a deep 
groove that extends along the borders of the catalytic and dimerization 
domains and houses the active site. This well-defined and negatively 
charged cavity is shaped from the top by strand β17 and α10 and in 
the middle by the loop connecting these two elements (residues 321–
328). The bottom of the cavity is formed by a loop (residues 132–142) 
connecting β-strands β6 and α5 and a loop (residues 341–355) 
connecting β18 and β19. Because the substrate has a linear shape, we 
predict that it binds in an extended conformation, lining up along the 
groove with the peptide bond positioned right over the active site 
metals. DapE enzymes have strict specificity for the L,L-isoform of 
SDAP.24 This specificity is built into the active site that includes both 
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the dinuclear metal cluster and adjacent amino acid residues that form 
a substrate binding cavity groove. Several studies indicate that 
substrate binding pockets play an important role in substrate 
recognition and binding for metallohydrolases.51–53 Insight into the role 
of this cavity comes from the structure of the [ZnZn(NmDapE)]-L-
captopril complex as several interactions between the inhibitor and 
residues within this cavity are formed. The L-captopril peptide bond 
forms a hydrogen bond with a well-ordered water molecule, which is 
stabilized by R179 and P165. In addition, the carboxyl terminus of the 
dipeptide is held in position by ionic interactions between N346 and 
G325. Interestingly, the carboxyl group also forms a hydrogen bond 
with the hydroxyl moiety of Y198, which resides on the other subunit 
of the dimer. This interaction is of great interest, because it is the first 
evidence of a residue from the second subunit interacting with an 
inhibitor bound to the first subunit. These data suggest a heretofore 
unknown function for dimer formation of DapE enzymes. Specifically, 
this indicates that the dimerization domain not only is crucial for dimer 
formation but also could play an important role in substrate 
recognition and binding. This is consistent with the findings that 
dimerization domain deletion mutants of HiDapE are inactive, 
highlighting the importance of DapE dimer formation.16 
In summary, a major limitation in developing a previously 
undescribed class of antimicrobials that target DapE enzymes has been 
the lack of knowledge about binding of the inhibitor to the DapE active 
site, including potential residues involved in substrate recognition and 
binding. We have spectroscopically and crystallographically 
characterized the binding of the competitive inhibitor L-captopril to 
DapE. The thiol moiety of L-captopril coordinates to both active site 
metal ions in a μ-thiolate fashion. No other inhibitor-centered ligands 
interact with the active site metal ions. Analysis of the first X-ray 
crystal structure of a DapE enzyme bound to an exogenous ligand, the 
[ZnZn(NmDapE)]–L-captopril complex, allowed for identification of 
several important active site pocket residues. These include R179, 
P165, and N346 that form hydrogen bonds to the functional groups of 
L-captopril. Remarkably, Y198 from one subunit was discovered to be 
involved in hydrogen bond formation with the L-captopril bound to the 
active site of the opposite subunit. This unforeseen hydrogen bonding 
interaction may be critical for catalysis and may also prove to be 
crucial in the development of novel medicinal chemistry leads. Because 
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L-captopril is an angiotensin-converting enzyme (ACE) inhibitor and a 
moderately strong inhibitor of DapE enzymes, understanding the 
electronic and structural properties of binding of L-captopril to the 
active site of DapE provides a foundation for the design of new, more 
potent DapE inhibitors. 
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Figure SI-1. MCD spectra of NmDapE with 1 and 2 eq. of added Co
2+
. The enzyme 
concentration was 29 mg/mL in 60/40 (v/v) glycerol/buffer (0.70 mM in protein, 1.4 mM in 
active sites). The spectra were recorded at 1.5 K and 7.0 T in a 0.63 cm path length cell. The 
MCD peaks due to four-coordinate (4-C) and six-coordinate (6-C) Co
2+
 are indicated. The 
binding affinities of both sites appear to be nearly equal. 
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Figure SI-2. MCD spectra of HiDapE with 1 and 2 eq. of added Co
2+
. The enzyme concentration 
was 33 mg/mL in 60/40 (v/v) glycerol/buffer (0.80 mM in protein, 1.6 mM in active sites). The 
spectra were recorded at 1.5 K and 7.0 T in a 0.63 cm path length cell. The MCD peaks due to 
four-coordinate (4-C) and six-coordinate (6-C)  Co
2+
 are indicated. The binding affinity of the 
four-coordinate site appears to be much higher than the six-coordinate site. 
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Figure SI-3. Magnetization plot of the VTVH MCD data collected on the 503 nm band in 
CoCoNmDapE. Key ground state electronic parameters are given in the figure and are typical for 
six-coordinate high-spin Co
2+
. 
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Figure SI-4. Magnetization plot of the VTVH MCD data collected on the 503 nm band in 
CoCoHiDapE. Key ground state electronic parameters are given in the figure and are typical for 
six-coordinate high-spin Co
2+
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Figure SI-5. Magnetization plot of the VTVH MCD data collected on the 532 nm band in 
CoCoNmDapE. Key ground state electronic parameters are given in the figure and are typical for 
four-coordinate high-spin Co
2+
. 
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Figure SI-6.  Magnetization plot of the VTVH MCD data collected on the 532 nm band in 
CoCoHiDapE. Key ground state electronic parameters are given in the figure and are typical for 
four-coordinate high-spin Co
2+
. 
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Figure SI-7. Magnetization plot of the VTVH MCD data collected on the 576 nm band in 
CoCoNmDapE. Key ground state electronic parameters are given in the figure and are typical for 
four-coordinate high-spin Co
2+
. 
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Figure SI-8. Magnetization plot of the VTVH MCD data collected on the 576 nm band in 
CoCoHiDapE. Key ground state electronic parameters are given in the figure and are typical for 
four-coordinate high-spin Co
2+
. 
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Figure SI-9. Magnetization plot of the VTVH MCD data collected on the 505 nm band in 
CoCoHiDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the 
figure and are typical for four-coordinate high-spin Co
2+
. 
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Figure SI-10. Magnetization plot of the VTVH MCD data collected on the 530 nm band in 
CoCoHiDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the 
figure and are typical for four-coordinate high-spin Co
2+
. 
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Figure SI-11. Magnetization plot of the VTVH MCD data collected on the 604 nm band in 
CoCoNmDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the 
figure and are typical for four-coordinate high-spin Co
2+
. 
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Figure SI-12. Magnetization plot of the VTVH MCD data collected on the 604 nm band in 
CoCoHiDapE with 5 eq. of captopril. Key ground state electronic parameters are given in the 
figure and are typical for four-coordinate high-spin Co
2+
. 
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Figure SI-13. (A) Structure of [Co2(µ-OH)(µ-1,3-CF3COO)2(Me3TACN)2]
+
. (B) MCD spectrum 
of [Co2(µ-OH)(µ-1,3-CF3COO)2(Me3TACN)2]
+
 in ethanol taken at 1.3 K and 7.0 T. (C) 
Magnetization plot for the 462 nm band of the complex. The complex was synthesized according 
to Lachicotte, R.; Kitayforodskiy, A.; Hagen, K. S. J. Am. Chem. Soc. 1993, 115, 8883-8884. 
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Figure SI-14. (A) Structure of CoF and CoH. (B) MCD spectra of CoH and CoF. The spectrum 
of CoH was taken as a solid mull at 1.3 K and 7.0 T. The spectrum of CoF was taken as a 2.5 
mM solution in EtOH at 1.3 K and 7.0 T. (C) Magnetization plot for the 497 nm band of CoF. 
The VTVH MCD data from CoH were also fitted (not shown) and the fit parameters are: J = -
0.65 cm
-1
, D = 64 cm
-1
, E/D = 0.33, y-polarized, χ
2
 = 0.07.  CoF and CoH were synthesized 
according to Lachicotte, R.; Kitayforodskiy, A.; Hagen, K. S. J. Am. Chem. Soc. 1993, 115, 
8883-8884. 
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